Quantcast

Latest End Stage Renal Disease Stories

2011-08-08 11:19:00

Michigan Dialysis Summit will feature Congressman John Conyers (MI-14), Patient Advocate Julia Herzog and Dr. Robert Provenzano, VP of Medical Affairs at DaVita DEARBORN, Mich., Aug. 8, 2011 /PRNewswire-USNewswire/ -- On Friday, August 12, from 9:30 a.m. to 11:30 a.m., members of the Dearborn-area community will come together to raise awareness about chronic kidney disease (CKD) at the Sanford-Brown College Dearborn Campus. The Michigan Dialysis Summit will focus on bringing attention...

2011-07-31 00:02:09

Central New York (CNY) Dialysis has entered into a transaction with DaVita Inc., a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and chronic kidney disease (CKD), to provide consulting and administrative services at the clinic. Syracuse, NY (PRWEB) July 30, 2011 Central New York (CNY) Dialysis has entered into a transaction with DaVita Inc., a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD)...

2011-07-12 06:30:00

LAWRENCE, Mass., July 12, 2011 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced the appointment of Barry M. Straube, M.D., to its Board of Directors. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) Dr. Straube is the Immediate Past Chief Medical Officer for the Centers for Medicare & Medicaid Services (CMS), as well as the Immediate Past Director of the CMS Office of...

2011-06-24 14:45:00

Legislation Disproportionately Cuts Vital Medicaid Funding for Patients with Kidney Failure ST. PAUL, Minn., June 24, 2011 /PRNewswire-USNewswire/ -- The Minnesota kidney care community expressed concern today over the Health and Human Services (HHS) omnibus budget bill (Senate File 760), which would significantly impact Minnesota dialysis patients' access to care, as well as vital health care jobs. SF 760 would cut Medicaid reimbursement to providers, including dialysis facilities, by...

2011-05-02 07:00:00

NEW YORK, May 2, 2011 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX), announced today that it has received positive Scientific Advice from the European Medicines Agency (EMA) for the development of Zerenex(TM) (ferric citrate) for the management and control of serum phosphorus in end-stage renal disease (ESRD) patients undergoing dialysis, and in pre-dialysis chronic kidney disease patients (CKD). The Scientific Advice from the EMA indicates that the Company's current Phase...

2011-04-28 15:00:00

NEW YORK, April 28, 2011 /PRNewswire/ -- Keryx Biopharmaceuticals (Nasdaq: KERX) today announced the final dataset from the Phase 3 short-term clinical trial of Zerenex((TM)) (ferric citrate) for the treatment of hyperphosphatemia in end-stage renal disease patients on dialysis. The Zerenex data was presented earlier today at the National Kidney Foundation Spring Clinical Meetings being held in Las Vegas, Nevada, in an oral presentation by David S. Goldfarb, M.D., Clinical Chief of...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related